Lipoglycopeptide Antibacterial class drugs

4 results

  • dalvance

    (Dalbavancin)
    Allergan, Inc.
    DALVANCE® is indicated for treating acute bacterial skin and skin structure infections (ABSSSI) in adults and pediatrics caused by specific Gram-positive bacteria, including methicillin-susceptible and methicillin-resistant Staphylococcus aureus, and various Streptococcus and Enterococcus species. Usage should target infections caused by susceptible strains to minimize resistance.
    Medication Details
    Drug Interactions

  • kimyrsa

    (oritavancin diphosphate)
    Melinta Therapeutics, LLC
    KIMYRSA® is indicated for treating adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by specific Gram-positive bacteria, including methicillin-susceptible and resistant Staphylococcus aureus, various Streptococcus species, and vancomycin-susceptible Enterococcus faecalis. Use only for proven or suspected susceptible infections.
    Medication Details
    Drug Interactions

  • orbactiv

    (oritavancin)
    Melinta Therapeutics, LLC
    ORBACTIV® (oritavancin) is indicated for treating adult patients with acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and vancomycin-susceptible Enterococcus faecalis. It should be used to prevent drug-resistant bacteria and tailored based on culture results when available.
    Medication Details
    Drug Interactions

  • vibativ

    (telavancin hydrochloride)
    Cumberland Pharmaceuticals Inc.
    VIBATIV is indicated for adults with complicated skin and skin structure infections (cSSSI) and hospital-acquired or ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible Gram-positive organisms, including methicillin-susceptible and -resistant Staphylococcus aureus. It may be used as empiric therapy in certain cases.
    Medication Details
    Drug Interactions